Patents by Inventor Sarah Ballantyne

Sarah Ballantyne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8206717
    Abstract: The invention provides the antibody 2C3 and target binding members based on 2C3 which binds interleukin-25. These are useful in therapy, e.g. the treatment of asthma.
    Type: Grant
    Filed: April 17, 2008
    Date of Patent: June 26, 2012
    Assignee: Medical Research Council
    Inventors: Andrew Neil James McKenzie, Sarah Ballantyne
  • Publication number: 20100129380
    Abstract: The invention provides the antibody 2C3 and target binding members based on 2C3 which binds interleukin-25. These are useful in therapy, e.g. the treatment of asthma.
    Type: Application
    Filed: April 17, 2008
    Publication date: May 27, 2010
    Inventors: Andrew Neil James McKenzie, Sarah Ballantyne